Visão selecionada em Inglês
Descritor em português: | Fator Ativador de Células B | ||||||
Descritor em inglês: | B-Cell Activating Factor | ||||||
Descritor em espanhol: |
Factor Activador de Células B
| ||||||
Descritor em francês: | Facteur d'activation des lymphocytes B | ||||||
Termo(s) alternativo(s): |
Activating Factor, B-Cell Activating Factor, B-Lymphocyte Antigen, CD257 Antigens, CD257 B Cell Activating Factor B Lymphocyte Activating Factor B Lymphocyte Stimulator B-Lymphocyte Activating Factor BAFF Ligand BLyS Protein CD257 Antigen CD257 Antigens TALL 1 Protein TALL-1 Protein THANK Protein TNF Superfamily, Member 13b TNF and APOL Related Leukocyte Expressed Ligand 1 TNF and APOL-Related Leukocyte Expressed Ligand 1 TNFSF13B Protein Tumor Necrosis Factor Ligand Superfamily Member 13b |
||||||
Código(s) hierárquico(s): |
D12.644.276.374.750.061 D12.776.395.191 D12.776.467.374.750.061 D12.776.543.550.193 D23.529.374.750.061 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D053264 | ||||||
Nota de escopo: | A tumor necrosis factor superfamily member that plays a role in the regulation of B-LYMPHOCYTE survival. It occurs as a membrane-bound protein that is cleaved to release an biologically active soluble form with specificity to TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; B-CELL ACTIVATION FACTOR RECEPTOR; and B-CELL MATURATION ANTIGEN. |
||||||
Qualificadores permitidos: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Nota MeSH pública: | 2007; B-CELL ACTIVATING FACTOR was indexed under TUMOR NECROSIS FACTOR ALPHA & MEMBRANE PROTEINS 1999-2006 |
||||||
Nota histórica: | 2007(1999) |
||||||
Identificador DeCS: | 52289 | ||||||
ID do descritor: | D053264 | ||||||
Documentos indexados na Biblioteca Virtual em Saúde (BVS): | Clique aqui para acessar os documentos da BVS | ||||||
Data de estabelecimento: | 01/01/2007 | ||||||
Data de entrada: | 05/07/2006 | ||||||
Data de revisão: | 24/05/2017 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
B-Cell Activating Factor
- Conceito preferido
Identificador do conceito |
M0305108 |
Nota de escopo | A tumor necrosis factor superfamily member that plays a role in the regulation of B-LYMPHOCYTE survival. It occurs as a membrane-bound protein that is cleaved to release an biologically active soluble form with specificity to TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; B-CELL ACTIVATION FACTOR RECEPTOR; and B-CELL MATURATION ANTIGEN. |
Termo preferido | B-Cell Activating Factor |
Termo(s) alternativo(s) |
Activating Factor, B-Cell Activating Factor, B-Lymphocyte Antigen, CD257 Antigens, CD257 B Cell Activating Factor B Lymphocyte Activating Factor B Lymphocyte Stimulator B-Lymphocyte Activating Factor BAFF Ligand BLyS Protein CD257 Antigen CD257 Antigens TALL 1 Protein TALL-1 Protein THANK Protein TNF Superfamily, Member 13b TNF and APOL Related Leukocyte Expressed Ligand 1 TNF and APOL-Related Leukocyte Expressed Ligand 1 TNFSF13B Protein Tumor Necrosis Factor Ligand Superfamily Member 13b |
Queremos a sua opinião sobre o novo sitio web do DeCS/MeSH
Convidamos-lhe a responder a uma pesquisa que não levará mais que 3 minutos
Ir para pesquisa